Menjugate conjugate vaccine: Phase III data

In a U.S. Phase III trial comparing Menjugate to Menomune meningococcal polysaccharide vaccine from sanofi-aventis Group (Euronext:SAN; SNY, Paris, France), Menjugate met the efficacy endpoint of non...